Skip to content

Quicktome Software Suite

by Omniscient Neurotechnology Pty Ltd (O8t)

510(k) K222359

Active European Union and United States

CE MDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK222359 Date30 May 2023ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
4 Aug 2022
FDA decision
30 May 2023 (Substantially Equivalent)
FDA review time
299 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K222359 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K222359 decided 30 May 2023 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
LLZ
Device class
Class II
Regulation
21 CFR Part 892.2050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Quicktome Software Suite is a connectomic analysis platform designed for advanced brain mapping and functional imaging analysis. It leverages AI-enabled post-processing to analyze MRI and resting-state functional MRI (rs-fMRI) data, generating detailed insights into patient-specific brain networks and connectivity patterns. This software supports neurosurgical planning by providing precise, actionable visualizations of brain structures and pathways.

The Quicktome Software Suite is supplied as a digital platform for use in clinical settings, including neurosurgical planning environments. It is intended for single-use per patient analysis, with no specified sterility requirements as it is non-invasive software. The system operates under FDA 510(k) clearance (K222359) and EU MDR compliance, with no restrictions on MRI safety as it is not a physical device. No physical storage or disposal requirements apply beyond standard IT infrastructure protocols.

Devices cleared under K222359

4 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K222359
UDI-DISize and differences
Quicktome Software Suite 2.1
Omniscient Neurotechnology Pty Ltd (O8t)
SCI0006 / 2.109358140000055 —On the market
Quicktome Software Suite 2.2
Omniscient Neurotechnology Pty Ltd (O8t)
SCI0006 / 2.209358140000062 —On the market
Quicktome Software Suite 2.3
Omniscient Neurotechnology Pty Ltd (O8t)
SCI0006 / 2.309358140000079 —On the market
Quicktome Software Suite 2.4
Omniscient Neurotechnology Pty Ltd (O8t)
SCI0006 / 2.409358140000093 —On the market

Similar devices

Other devices filed under FDA product code LLZ (System, Image Processing, Radiological).

Other devices from Omniscient Neurotechnology Pty Ltd (O8t)

See all devices from Omniscient Neurotechnology Pty Ltd (O8t) →